Document:

Loan Modification Agreement

 Exhibit 10.1 
 LOAN MODIFICATION AGREEMENT 
 This Loan Modification Agreement (the
“Agreement”) is entered into as of March 30, 2012, by and between ISTA PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”) and SILICON VALLEY BANK (“Bank”). 

1. DESCRIPTION OF EXISTING INDEBTEDNESS: Among other indebtedness which may be owing by Borrower to Bank, Borrower is indebted to Bank pursuant to
an Amended and Restated Loan and Security Agreement, dated February 23, 2011 (as may be amended from time to time the “Loan Agreement”). Capitalized terms used but not otherwise defined herein shall have the same meanings as in
the Loan Agreement. 
 2. DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by the Collateral. 

3. DESCRIPTION OF CHANGE IN TERMS. 
  

	 	A.	Modification to Loan Agreement. 

  

	 	1.	Notwithstanding anything to the contrary in the Loan Agreement or any other Loan Document, and subject to the satisfaction of the conditions to the effectiveness of
this Agreement: 

  

	 	(i)	the Letters of Credit Sublimit, Foreign Exchange Sublimit and Cash Management Services Sublimit, and the obligation of Bank to make any Credit Extensions or issue any
Letters of Credit under the Loan Agreement in respect thereof, is hereby terminated; 

  

	 	(ii)	Borrower’s right to request Credit Extensions and/or Letters of Credit in connection with the Letters of Credit Sublimit, Foreign Exchange Sublimit and Cash
Management Services Sublimit under the Loan Agreement is hereby terminated; and 

  

	 	(iii)	Section 2.2.2 (Letters of Credit Sublimit), Section 2.2.3 (Foreign Exchange Sublimit) and Section 2.2.4 (Cash Management Services Sublimit), all
references to the Letters of Credit Sublimit, Foreign Exchange Sublimit, and Cash Management Services Sublimit in any definition or provision in the Loan Agreement (including any exhibits thereto) or any other Loan Document, and all definitions and
provisions relating solely to the Letters of Credit Sublimit, Foreign Exchange Sublimit, and Cash Management Services Sublimit in the Loan Agreement (including any exhibits thereto) and each other Loan Document are of no further force or effect.

  

	 	2.	The termination of the Letters of Credit Sublimit, Foreign Exchange Sublimit and Cash Management Services Sublimit as set forth herein shall not be deemed to
(i) be a termination or modification of any other term or condition of the Loan Agreement or any Loan Document, or (ii) prejudice any right or remedy which Bank may now have or may have in the future (except to the extent such right or
remedy which Bank may now have or may have in the future is based upon an Event of Defaults that was waived in writing by Bank) under or in connection with the Loan Agreement or any Loan Document. 

 

	 	3.	Notwithstanding the termination of the Letters of Credit Sublimit, Foreign Exchange Sublimit and Cash Management Services Sublimit as set forth herein, any obligation
incurred by Borrower in respect of the Letters of Credit Sublimit, the Foreign Exchange Sublimit or the Cash Management Services Sublimit, or hereafter incurred by Borrower in respect of any separate facility relating to letters of credit, cash
management services or foreign exchange contracts, shall constitute part of the Obligations under the Loan Agreement and be secured by the Loan Documents. 

  
 1 

	 	4.	Clause (b) of Section 2.2.1 (Revolving Advances) is hereby deleted in its entirety and replaced with the following: 

(b) Termination; Repayment. The Revolving Line terminates on the earlier of (i) the Prepayment Date, or (ii) the
Revolving Line Maturity Date, when the principal amount of all Advances, the unpaid interest thereon, and all other Obligations relating to the Revolving Line shall be immediately due and payable. 

 

	 	5.	The following clause (c) is hereby added to Section 2.2.1 (Revolving Advances): 

(c) Prepayment. So long as an Event of Default has not occurred and is not continuing, Borrower shall have the option to prepay,
in whole, the Indebtedness hereunder and terminate the Revolving Line, provided, Borrower (a) provides written notice to Bank of its election to exercise to prepay at least three (3) days prior to such prepayment, and (b) pays,
on the date of the prepayment (the “Prepayment Date”) (i) all accrued and unpaid interest with respect to the outstanding principal amount of Advances through the Prepayment Date; (ii) the aggregate principal amount of
Advances outstanding as of the Prepayment Date; (iii) the Make-Whole Premium; and (iv) all other sums, if any, that are due and payable hereunder. The “Make-Whole Premium” is an amount equal to the Unused Revolving Line
Facility Fee calculated through the Revolving Line Maturity Date and based on the unused portion of the Revolving Line being equal to the maximum amount permitted thereunder. 

 

	 	6.	Clause (b) of Section 2.5 (Payment of Interest on Credit Extensions) is hereby deleted in its entirety and replaced with the following:

 (b) Advances. Each Advance shall bear interest on the outstanding principal amount thereof from the date
when made, continued or converted until paid in full at a rate per annum equal to the greater of (a) the Prime Rate, and (b) 4.00 percentage points (400 basis points). Pursuant to the terms hereof, interest on each Advance shall be paid in
arrears on the first Business Day of each month. Interest shall also be paid on the date of any prepayment of any Advance pursuant to this Agreement for the portion of any Advance so prepaid and upon payment (including prepayment) in full thereof.
All accrued but unpaid interest on the Advances shall be due and payable on the Revolving Line Maturity Date. 
  

	 	7.	Clause (d) of Section 2.6 (Fees) is hereby deleted in its entirety and replaced with the following: 

(a) Make Whole Premium. The Make-Whole Premium when due pursuant to the terms of Section 2.2.1(c). 

 

	 	8.	Clause (b), (c) and (d) of the definition of Eligible Accounts in Section 13.1 (Definitions) are hereby deleted in their entirety and replaced with the
following: 

 (b) Accounts that the Account Debtor has not paid within 90 days of due date; 

  
 2 

 (c) Accounts owing from an Account Debtor, fifty percent (50%) or more of whose
Accounts have not been paid within 90 days of due date; 
 (d) Credit balances over 90 days from due date; 

 

	 	9.	The definition of Prime Rate Margin in Section 13.1 (Definitions) is hereby deleted in its entirety without replacement. 

 

	 	10.	The definitions of “Current Liabilities” and “Revolving Loan Maturity Date” in Section 13.1 (Definitions) are hereby deleted in their entirety
and replaced with the following in alphabetical order: 

 “Current Liabilities”, as of any date
of determination, are all obligations and liabilities of Borrower to Bank, plus, without duplication, the aggregate amount of Borrower’s Total Liabilities that mature within one (1) year, less the current portion of Borrower’s Total
Liabilities that mature outside of one (1) year. 
 “Revolving Line Maturity Date” is the earliest of
(a) March 31, 2013; or (b) the date Bank exercises its remedies under Section 9.1(a). 
  

	 	11.	Clauses (a) and (b) of Section 6.6 (Financial Covenants) are hereby deleted in their entirety and replaced with the following: 

(b) Adjusted Quick Ratio. Borrower shall maintain, on a consolidated basis with respect to Borrower and its Subsidiaries a ratio
(“Adjusted Quick Ratio”) of Quick Assets to Current Liabilities greater than or equal to: (i) 0.65 to 1.00 as of February 29, 2012, March 31, 2012, April 30, 2012, May 31,
2012, June 30, 2012, July 31, 2012 and August 31, 2012; (ii) 0.50 to 1.00 as of September 30, 2012, October 31, 2012 and November 30, 2012; and (iii) 0.75 to 1.00 as of December 31, 2012
and the last day of each month thereafter. 
 (c) Tangible Net Worth. Borrower shall maintain, on a consolidated basis
with respect to Borrower and its Subsidiaries measured quarterly, Tangible Net Worth of not less than: (i) $20,000,000 at March 31, 2012; (ii) $25,000,000 at June 30, 2012; (iii) $5,000,000 at September 30, 2012; and
(iv) $20,000,000 at December 31, 2012 and the last day of each quarter thereafter. 
  

	 	12.	In furtherance of the amendment set forth in paragraph 11 above, Exhibit D of the Loan Agreement is hereby deleted in its entirety and replaced with Exhibit D attached
hereto. 

  

	 	B.	Modification to Loan Documents. The Loan Documents are hereby amended wherever necessary to be consistent with the changes to the Loan Agreement described above.

 4. NO DEFENSES OF BORROWER. Borrower agrees that, as of the date hereof, it has no defenses against the obligations to
pay any amounts arising under or in connection with the Loan Documents. 
 5. CONTINUING VALIDITY. Borrower understands and agrees that
in modifying the Loan Documents, Bank is relying upon Borrower’s representations, warranties, and agreements, as set forth in the Loan Documents. Except as expressly modified pursuant to this Agreement, the terms of the Loan Documents remain
unchanged and in full force and effect. Bank’s agreement to modify the Loan Documents pursuant to this Agreement shall in no way obligate Bank to make any future modifications to the Loan Documents. Nothing in this Agreement shall constitute a
satisfaction of the Obligations. 
 6. REPRESENTATIONS AND WARRANTIES. Borrower hereby certifies that all representations and warranties
of Borrower contained in the Loan Agreement are true, accurate and complete in all material respects as 

  
 3 

 
of the date hereof; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by
materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date. 

7. NO DEFAULT. Borrower hereby certifies no Default or Event of Default has occurred and is continuing or of the date hereof, or would result
after giving effect to this Agreement. 
 8. CONDITIONS. The effectiveness of this Agreement is conditioned upon the execution and
delivery of this Agreement and the receipt by Bank of a loan modification fee in the amount of Fifty Thousand Dollars ($50,000). 
 This Loan Modification Agreement is executed as of the date first written above. 
  

							
	BORROWER:	 	BANK:
	ISTA PHARMACEUTICALS, INC.	 	SILICON VALLEY BANK
				
	By:	 	 /s/ Lauren P. Silvernail
	 	By :	 	 /s/ Brett Maver

				
	Name:	 	 Lauren P. Silvernail
	 	Name:	 	 Brett Maver

				
	Title:	 	 CFO & V.P., Corporate Development
	 	Title:	 	 Relationship Manager

  
 4 

 EXHIBIT D 

COMPLIANCE CERTIFICATE 
  

	 TO: SILICON VALLEY BANK 
	 Date:                    

 FROM: ISTA PHARMACEUTICALS, INC. 
 The undersigned authorized officer of ISTA PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”) certifies that under the terms and conditions of the Amended and Restated Loan and Security
Agreement between Borrower and Bank (the “Agreement”), (1) Borrower is in complete compliance for the period ending              with all required covenants except as noted
below, (2) there are no Events of Default, (3) all representations and warranties in the Agreement are true and correct in all material respects on this date except as noted below; provided, however, that such materiality qualifier shall
not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true,
accurate and complete in all material respects as of such date, (4) Borrower, and each of its Subsidiaries, has timely filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes,
assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section 5.9 of the Agreement, and (5) no Liens have been levied or claims made against Borrower or any of its Subsidiaries
relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Bank. Attached are the required documents supporting the certification. The undersigned certifies that these are prepared in
accordance with generally GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes. The undersigned acknowledges that no borrowings may be requested at any time or date of determination that
Borrower is not in compliance with any of the terms of the Agreement, and that compliance is determined not just at the date this certificate is delivered. Capitalized terms used but not otherwise defined herein shall have the meanings given them in
the Agreement. 
  

					
	Please indicate compliance status by circling Yes/No under “Complies” column.
			
	 Reporting Covenant
	  	 Required
	  	 Complies

	 Monthly financial statements with Compliance Certificate
	  	Monthly within 30 days	  	Yes No
	 10-Q, 10-K and 8-K
	  	Within 5 days after filing with SEC	  	Yes No
	 Borrowing Base Certificate, A/R & A/P Agings
	  	Monthly within 20 days if borrowing	  	Yes No

  

							
	 Financial Covenant
	  	 Required
	  	 Actual
	  	 Complies

				
	Maintain:	  		  		  	
				
	Adjusted Quick Ratio, Monthly	  	*Applicable ratio per below	  	        :1.0	  	Yes No
				
	Tangible Net Worth, Quarterly	  	**Applicable amount per below	  	$        	  	Yes No

  

	*	greater than or equal to (i) 0.65 to 1.00 as of February 29, 2012, March 31, 2012, April 30, 2012, May 31,
2012, June 30, 2012, July 31, 2012 and August 31, 2012; (ii) 0.50 to 1.00 as of September 30, 2012, October 31, 2012 and November 30, 2012; and (iii) 0.75 to 1.00 as of December 31, 2012
and the last day of each month thereafter. 

  

	**	not less than (i) $20,000,000 at March 31, 2012; (ii) $25,000,000 at June 30, 2012; (iii) $5,000,000 at September 30, 2012; and
(iv) $20,000,000 at December 31, 2012 and the last day of each quarter thereafter. 

  
 5 

 The following financial covenant analyses and information set forth in Schedule 1 attached hereto are true
and accurate as of the date of this Certificate. 
 The following are the exceptions with respect to the certification above: (If no exceptions
exist, state “No exceptions to note.”) 
  

                         
                                         
                                         
                                         
                                         
                                         
                            
                                  
                                         
                                         
                                         
                                         
                                         
                    

                         
                                         
                                         
                                         
                                         
                                         
                            
  

							
	ISTA PHARMACEUTICALS, INC.	  	BANK USE ONLY
		 		  	Received by:	  	  

				
		 		  		  	AUTHORIZED SIGNER
				
	By:	 	  
	  	Date:	  	
				
	Name:	 		  	Verified:	  	  

				
	Title:	 		  		  	AUTHORIZED SIGNER
				
		 		  	Date:	  	
				
		 		  	Compliance Status:	  	        Yes         No

  
 6 

 Schedule 1 to Compliance Certificate 

Financial Covenants of Borrower 
 Dated:                      

 

	I.	Adjusted Quick Ratio (Section 6.6(a)) 

Required: See below 
 Actual: 

 

					
	A.	  	Aggregate value of the unrestricted cash and cash equivalents of Borrower and its Subsidiaries	  	$            
	B.	  	Aggregate value of the net billed accounts receivable of Borrower and its Subsidiaries	  	$
	C.	  	Aggregate value of the Investments with maturities of fewer than 12 months of Borrower and it Subsidiaries	  	$
	D.	  	Quick Assets (the sum of lines A through C)	  	$
	E.	  	Aggregate value of Obligations to Bank	  	$
	F.	  	Aggregate value of liabilities of Borrower and its Subsidiaries (including all Indebtedness) that matures within one (1) year	  	$
	G.	  	Current Portion of Subordinated Debt and Current Portion of long-term Indebtedness	  	$
	H.	  	Current Liabilities (the sum of lines E and F less G)	  	$
	I.	  	Value of Line D (Quick Assets)	  	$
	J.	  	Value of Line H (Current Liabilities)	  	$
	K.	  	Aggregate value of all amounts received or invoiced by Borrower in advance of performance under contracts and not yet recognized as revenue	  	$
	L.	  	Line J minus line K	  	$
	M.	  	Adjusted Quick Ratio (line I divided by line L)	  	

 Is line M equal to or greater than the applicable amount: (i) 0.65 to 1.00 as of February 29,
2012, March 31, 2012, April 30, 2012, May 31, 2012, June 30, 2012, July 31, 2012 and August 31, 2012; (ii) 0.50 to 1.00 as of September 30, 2012, October 31, 2012 and
November 30, 2012; and (iii) 0.75 to 1.00 as of December 31, 2012 and the last day of each month thereafter? 
  

			
	              No, not in compliance
	  	             Yes, in compliance

  

	II.	Tangible Net Worth (Section 6.6(b)) 

Required: See below 
 Actual: 

 

					
	 A.
	  	Aggregate value of liabilities of Borrower and its Subsidiaries (including all Indebtedness and Warrant liability associated with the Deerfield Facility Agreement) and current
portion of Subordinated Debt permitted by Bank to be paid by Borrower (but no other Subordinated Debt)	  	$            
	B.	  	Aggregate value of Indebtedness of Borrower subordinated to Borrower’s Indebtedness to Bank and net (+or -) Warrant mark-to-market of Warrant associated with the Deerfield
Facility Agreement	  	$
	C.	  	Debt (line A minus line B)	  	$
	D.	  	Aggregate value of total assets of Borrower and its Subsidiaries	  	$
	E.	  	Aggregate value of goodwill of Borrower and its Subsidiaries	  	$
	F.	  	Aggregate value of intangible assets of Borrower and its Subsidiaries	  	$
	G.	  	Aggregate value of any reserves not already deducted from assets	  	$
	H.	  	Value of line C	  	$
	I.	  	Tangible Net Worth (line D minus line E minus line F minus line G minus line H)	  	$

  
 7 

 Is line I greater than or equal to applicable amount: (i) $20,000,000 at March 31, 2012;
(ii) $25,000,000 at June 30, 2012; (iii) $5,000,000 at September 30, 2012; or (iv) $20,000,000 at December 31, 2012 and the last day of each quarter thereafter? 

 

			
	              No, not in compliance
	  	             Yes, in compliance

  
 8Nominating Agreement

 Exhibit 10.1 
 NOMINATING AGREEMENT 
 This Nominating Agreement (this
“Agreement”), dated as of April 3, 2012, by and among Rexnord Corporation, a Delaware corporation (the “Company”), and Apollo Management VI, L.P. (“Apollo Management”). 

WHEREAS, the Company has determined that it is in its best interests to effect an initial public offering (“IPO”) of
shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”); 
 WHEREAS, in
connection with the IPO, the Company and Apollo (as defined below) desire to enter into this Agreement setting forth certain rights and obligations with respect to the shares of Common Stock owned by Apollo. 

NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto,
intending to be legally bound, hereby agree as follows: 
 SECTION 1. Definitions. As used in this Agreement, the following terms shall
have the following respective meanings: 
 (a) “Affiliate” has the meaning given to that term in
Rule 12b-2 under the Securities Exchange Act of 1934, as amended. 
 (b) “Apollo” means Apollo
Management, Apollo Management, L.P. and any of their Affiliates and any shares of Common Stock over which Apollo Management, Apollo Management, L.P., any of their Affiliates have voting or dispositive power (it being acknowledged that the term
“Affiliates” does not include George M. Sherman, any director employed by George M. Sherman, any of his Affiliates or any director employed by the Company). 

(c) “Apollo Designee” shall mean any person nominated at any time and from time to time by Apollo
pursuant to Section 2 to serve on the Board of Directors of the Corporation. 
 (d)
“person” means any individual, firm, corporation, general or limited partnership, limited liability company, trust, joint venture or other entity or association, including without limitation any governmental authority, and shall
include any successor (by merger or otherwise) of such entity. 
 (e) “Organizational Documents”
means the Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws of the Company, as either may be amended from time to time. 

  
 1 

 SECTION 2. Board Representation. 

(a) Until such time as Apollo no longer beneficially owns at least 50.1% of the total number of shares of Common Stock
outstanding at any time, the Company shall support the nomination of, and cause the Board of Directors of the Company (the “Board of Directors”) to include in the slate of nominees recommended to stockholders for election as
directors, four (4) persons designated at any time and from time to time by Apollo Management; 
 (b) After
such time as Apollo no longer beneficially owns at least 50.1%, but until such time as Apollo no longer beneficially owns at least 33 1/3% of the total number of shares of Common Stock outstanding at any time, the Company shall support the
nomination of, and cause the Board of Directors to include in the slate of nominees recommended to stockholders for election as directors, three (3) persons designated at any time and from time to time by Apollo Management; 

(c) Until such time as Apollo no longer beneficially owns at least 50.1% of the total number of shares of Common Stock
outstanding at any time, upon written request from Apollo Management, the Company promptly shall take all action as shall be necessary to, and shall cause the Board of Directors of the Company to, increase the size of the Board of Directors by such
number that will cause Apollo Designees to constitute a majority of the positions on the Board of Directors, and the Company shall cause the Board of Directors promptly to fill the vacancies created by such increase with Apollo Designees and shall,
at the annual stockholder meeting following such written request from Apollo Management, support the nomination of, and cause the Board of Directors to include in the slate of nominees recommended to stockholders for election as directors, Apollo
Designees to fill such vacancies (in addition to the four (4) Apollo Designees referred to in clause (a)); 
 provided,
however, that, notwithstanding the foregoing subsections (a), (b) and (c), the Company shall not be required to take any action which it reasonably believes is unlawful, and the Company shall be allowed to take any action the omission of which
it reasonably believes would be unlawful. 
 (d) Until such time as Apollo no longer beneficially owns at least
33 1/3% of the total number of shares of Common Stock outstanding at any time, vacancies arising through the death, resignation or removal of an Apollo Designee may be filled only by a majority of the directors nominated by Apollo Management then in
office and the directors so chosen shall hold office until the next annual election and until their successors are duly elected and qualified, or until their earlier death, resignation or removal. 

(e) Until such time as Apollo no longer beneficially owns at least 50.1% of the total number of shares of Common Stock
outstanding at any time, vacancies arising from an increase in the number of directors pursuant to Section 2(c) hereof may be filled only by a majority of the directors nominated by Apollo Management then in office and the directors so chosen
shall hold office until the next annual election and until their 

  
 2 

 
successors are duly elected and qualified, or until their earlier death, resignation or removal. 
 (f) Notwithstanding the provisions of this Section 2, Apollo Management shall not be entitled to designate any person as a nominee to the Board of Directors if the Company receives a written opinion
of its outside legal counsel of national reputation that such person would not be qualified under any applicable law, rule or regulation, rule of the New York Stock Exchange or the Amended and Restated By-Laws of the Corporation (the
“By-Laws”) to serve as a director of the Company. Other than with respect to the issue set forth in the preceding sentence, the Company shall not have the right to object to any Apollo Designee. The Company shall notify Apollo
Management in writing of the date on which proxy materials are expected to be mailed by the Company in connection with an election of directors (and such notice shall be delivered to Apollo Management at least 30 days prior to such expected mailing
date). The Company shall notify Apollo Management of any objection to an Apollo Designee sufficiently in advance of the date on which such proxy materials are to be mailed by the Company in connection with such election of directors so as to enable
Apollo Management to propose a replacement Apollo Designee in accordance with the terms of this Agreement. 
 SECTION 3. Apollo Approval
Rights. 
 (a) Subject to the provisions of subsection (b), without the approval of a majority of a quorum of
the entire Board of Directors, which must include the approval of a majority of the directors nominated by Apollo Management voting on such matter, the Company shall not, and (to the extent applicable) shall not permit any subsidiary of the Company
to, take any of the actions prohibited by Section 3.6 of the By-Laws. 
 (b) The approval rights set
forth in Section 3.6 of the By-Laws shall terminate at such time as Apollo no longer beneficially owns at least 33 1/3% of the total number of shares of Common Stock outstanding at any time. 

SECTION 4. Miscellaneous. 
 (a) Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to its principles of conflicts of laws.

 (b) Certain Adjustments. The provisions of this Agreement shall apply to the full extent set forth
herein with respect to any and all shares of capital stock of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise) that may be issued in respect of, in exchange for, or in substitution
for the shares of Common Stock, by combination, recapitalization, reclassification, merger, consolidation or otherwise and the term “Common Stock” shall include all such other securities. In the event of any change in the capitalization of
the Company, as a result of any stock split, stock dividend or stock combination or otherwise, the provisions of this Agreement shall be appropriately adjusted. 

  
 3 

 (c) Enforcement. The parties expressly agree that the provisions of
this Agreement may be specifically enforced against each of the parties hereto in any court of competent jurisdiction. 
 (d) Successors and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors, and
administrators of the parties hereto. 
 (e) Entire Agreement. This Agreement, together with the By-Laws,
constitutes the full and entire understanding and agreement between the parties with regard to the subject matter hereof and supersedes all prior oral or written (and all contemporaneous oral) agreements or understandings with respect to the subject
matter hereof. In the event of a conflict between the By-Laws and this Agreement, the provisions of the By-Laws shall control. 
 (f) Notices, etc. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, return receipt requested, postage
prepaid or otherwise delivered by hand, messenger, e-mail or facsimile transmission, addressed: 
 if to Apollo
or Apollo Management: 
 c/o Apollo Management, L.P. 

9 W. 57th Street 
 43rd Floor

 New York, NY 10019 
 Attention: Laurie D. Medley 
 Facsimile: (646) 607-0528 

E-mail: lmedley@apollolp.com 
 with a copy to 
 c/o Apollo Management, L.P. 

2000 Avenue of the Stars 
 Suite 510 North 
 Los Angeles, CA 90067 

Attention: Damian Giangiacomo 
 Facsimile: (310) 878-0198 
 E-mail: damian@apollolp.com 

if to the Company: 
 4701 West Greenfield Avenue 
 Milwaukee, WI 53214 

Attention: General Counsel 
 Facsimile:  (414) 643-3078 
 E-mail: patty.whaley@rexnord.com

 or at such other address as the Company or Apollo shall have furnished to the other in writing. 

Each such notice or other communication shall for all purposes of this Agreement be treated as effective or as having been given when
delivered, if delivered by hand or by messenger (or overnight courier), 24 hours after confirmed receipt if sent by facsimile or 

  
 4 

 
e-mail transmission or at the earlier of its receipt or on the fifth day after mailing, if mailed, as aforesaid. 

(g) Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party hereto
upon any breach or default of the Company under this Agreement, shall impair any such right, power or remedy of such party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar
breach or default thereunder occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default therefore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the
part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such
writing. All remedies, either under this Agreement, or by law or otherwise afforded to any party, shall be cumulative and not alternative. 
 (h) Counterparts. This Agreement may be executed in any number of counterparts, including .pdf or facsimile copies thereof, each of which may be executed by less than all of the parties hereto,
each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one instrument. 
 (i) Severability. If any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be
affected or impaired thereby. 
 (j) Amendments and Waivers. The provisions of this Agreement may be
amended at any time and from time to time, and particular provisions of this Agreement may be waived or modified, with and only with an agreement or consent in writing signed by the Company and Apollo Management. 

(k) Jurisdiction. The parties hereto irrevocably submit, in any legal action or proceeding relating to this
Agreement, to the jurisdiction of the courts of the United States located in the State of Delaware or in any Delaware state court and consent that any such action or proceeding may be brought in such courts and waive any objection that they may now
or hereafter have to the venue of such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient forum. 
 (l) Further Assurances. The parties agree to use their best efforts and act in good faith in carrying out their obligations under this Agreement. The parties also agree, without further
consideration, to execute such further instruments and to take such further actions as may be necessary or desirable to carry out the purposes and intent of this Agreement. 

(m) Enforcement. The parties expressly agree that the provisions of this Agreement may be specifically enforced
against each of the parties hereto in any court of competent jurisdiction. 

  
 5 

 (n) Termination. This Agreement shall automatically terminate at such
time as Apollo no longer beneficially owns at least 33 1/3% of the total number of shares of Common Stock outstanding. 

[Remainder of page intentionally left blank] 

  
 6 

 IN WITNESS WHEREOF, each of the parties hereto has executed this Agreement as of the date
first above written. 
  

			
	REXNORD CORPORATION
		
	 By:
	 	 /s/ Patricia M. Whaley

	 Name: Patricia M. Whaley

	 Title: VP, General Counsel & Secretary

	
	APOLLO MANAGEMENT VI, L.P.
		
	 By:
	 	 AIF VI Management, LLC, its General Partner

		
	 By:
	 	 /s/ Laurie Medley

	 Name: Laurie Medley

	 Title: Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]